Skip to content

Circles

A

Alnylam Pharmaceuticals, Inc.

ALNY· Nasdaq

A

ALNYAlnylam Pharmaceuticals, Inc.

ALNYAlnylam Pharmaceuticals, Inc.·Earnings record

Q3 2026

Previous · Q2 2026

Q3 2026 · 10-Qprojected

Upcoming

Alnylam Pharmaceuticals, Inc.’s Q3 2026 10-Q window runs Oct 27, 2026 to Nov 4, 2026.

Based on 8 prior 10-Q filings.

Quarterly history

…Q3 ’24 Q4 ’24^d Q1 ’25 Q2 ’25 Q3 ’25 Q4 ’25^d Q1 ’26 Q2 ’26Q3 ’26

Alnylam Pharmaceuticals, Inc. · CIK 1178670 · Engraved from SEC EDGAR

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Circles Account Terms Privacy